Open access
21
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors
Sang-Soo Kim1 Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA;2 SynerGene Therapeutics, Inc, Potomac, MD, USA
, Manish Moghe1 Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USAhttps://orcid.org/0000-0001-9680-1256
, Antonina Rait1 Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA
, Kathryn Donaldson1 Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USAhttps://orcid.org/0009-0001-6026-3940
, Joe B Harford2 SynerGene Therapeutics, Inc, Potomac, MD, USA
& Esther H Chang1 Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USACorrespondence[email protected]
https://orcid.org/0000-0003-0292-519X
https://orcid.org/0000-0003-0292-519X
Pages 5973-5993
|
Received 06 Jan 2024, Accepted 11 Jun 2024, Published online: 13 Jun 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.